George de Urioste - Jul 11, 2025 Form 4 Insider Report for HeartBeam, Inc. (BEAT)

Role
Director
Signature
/s/ George de Urioste
Stock symbol
BEAT
Transactions as of
Jul 11, 2025
Transactions value $
$0
Form type
4
Date filed
10/3/2025, 12:37 PM
Previous filing
Jul 2, 2025
Next filing
Dec 5, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
de Urioste George Director 2118 WALSH AVE, SUITE 210, SANTA CLARA /s/ George de Urioste 2025-10-02 0001270068

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BEAT Common Stock 57.1K Jul 11, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BEAT Restricted Stock Award 60.5K Jul 11, 2025 Common Stock 60.5K $0.00 Direct F1, F2
holding BEAT Common Stock (right to buy) 89.5K Jul 11, 2025 Common Stock 45.5K $1.65 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs) granted on July 11, 2025. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. 100% of the RSUs shall vest on the earlier of July 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's 2022 Equity Inventive Plan) through the applicable vesting date.
F2 RSUs do not expire, they either vest or are canceled prior to vesting date
F3 Granted options on September 30, 2025, one half of the total number of Shares subject to the Special Option shall vest on the three-month anniversary of the vesting commencement date (July 1, 2025) and the remaining Shares shall vest on the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.